Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 28.46%
March 31, 2026 29.81%
December 31, 2025 27.89%
September 30, 2025 28.31%
June 30, 2025 27.22%
March 31, 2025 31.23%
December 31, 2024 28.51%
September 30, 2024 28.00%
June 30, 2024 26.44%
March 31, 2024 28.95%
December 31, 2023 31.67%
September 30, 2023 24.08%
June 30, 2023 24.26%
March 31, 2023 21.27%
December 31, 2022 20.34%
September 30, 2022 20.85%
June 30, 2022 20.60%
March 31, 2022 24.83%
December 31, 2021 24.68%
September 30, 2021 27.59%
June 30, 2021 35.72%
March 31, 2021 33.68%
December 31, 2020 27.36%
September 30, 2020 29.40%
June 30, 2020 8.24%
Date Value
March 31, 2020 28.76%
December 31, 2019 28.39%
September 30, 2019 35.34%
June 30, 2019 28.79%
March 31, 2019 31.22%
December 31, 2018 27.84%
September 30, 2018 31.69%
June 30, 2018 28.00%
March 31, 2018 33.90%
December 31, 2017 -3.53%
September 30, 2017 36.96%
June 30, 2017 29.39%
March 31, 2017 26.60%
December 31, 2016 27.03%
September 30, 2016 30.83%
June 30, 2016 27.50%
March 31, 2016 22.98%
December 31, 2015 28.17%
September 30, 2015 28.40%
June 30, 2015 22.95%
March 31, 2015 18.23%
December 31, 2014 24.28%
September 30, 2014 22.49%
June 30, 2014 20.30%
March 31, 2014 9.53%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Stryker Corp. 19.37%
Zimmer Biomet Holdings, Inc. 9.17%
Abbott Laboratories 7.37%
Boston Scientific Corp. 16.63%
Globus Medical, Inc. 19.20%